Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1982 1
1985 1
1989 1
1992 1
1993 1
1996 3
1997 2
1998 2
2001 2
2002 2
2003 3
2004 2
2005 3
2006 6
2007 3
2008 2
2009 1
2010 3
2011 5
2012 2
2013 2
2014 4
2015 6
2016 4
2017 4
2018 2
2019 3
2020 5
2021 5
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Basal cell carcinoma, susceptibility to, 1"
Page 1
Insights into risk factors for basal cell carcinoma: a Mendelian randomization study.
Li W, Wang W. Li W, et al. Clin Exp Dermatol. 2023 Jun 5;48(6):676-680. doi: 10.1093/ced/llad046. Clin Exp Dermatol. 2023. PMID: 36815291
Basal cell carcinoma (BCC) is one of the most common skin cancers. ...This resulted in the present MR study that analysed 43 risk factors and demonstrates that telomere length [odds ratio (OR) 1.53, 95% confidence interval (CI) 1.35-1.74,
Basal cell carcinoma (BCC) is one of the most common skin cancers. ...This resulted in the present MR study that analys
Neoadjuvant Therapy for Non-melanoma Skin Cancer: Updated Therapeutic Approaches for Basal, Squamous, and Merkel Cell Carcinoma.
Zelin E, Zalaudek I, Agozzino M, Dianzani C, Dri A, Di Meo N, Giuffrida R, Marangi GF, Neagu N, Persichetti P, Toffoli L, Conforti C. Zelin E, et al. Curr Treat Options Oncol. 2021 Mar 16;22(4):35. doi: 10.1007/s11864-021-00826-3. Curr Treat Options Oncol. 2021. PMID: 33725197 Free PMC article. Review.
Targeted therapy with sonic hedgehog pathway inhibitors is very effective in locally advanced or multiple basal cell carcinomas while immunotherapy with immune checkpoint inhibitors appears to be promising for advanced cutaneous squamous cell carcinoma
Targeted therapy with sonic hedgehog pathway inhibitors is very effective in locally advanced or multiple basal cell carcinoma …
Neurocutaneous Syndromes and Brain Tumors.
Ullrich NJ. Ullrich NJ. J Child Neurol. 2016 Oct;31(12):1399-411. doi: 10.1177/0883073815604220. Epub 2015 Oct 12. J Child Neurol. 2016. PMID: 26459515 Review.
This review outlines the central nervous system tumors associated with underlying neurocutaneous disorders, including neurofibromatosis type 1, neurofibromatosis type 2, schwannomatosis, tuberous sclerosis complex, Von Hippel Lindau, and nevoid basal cell
This review outlines the central nervous system tumors associated with underlying neurocutaneous disorders, including neurofibromatosis type …
Disease risk scores for skin cancers.
Fontanillas P, Alipanahi B, Furlotte NA, Johnson M, Wilson CH; 23andMe Research Team; Pitts SJ, Gentleman R, Auton A. Fontanillas P, et al. Nat Commun. 2021 Jan 8;12(1):160. doi: 10.1038/s41467-020-20246-5. Nat Commun. 2021. PMID: 33420020 Free PMC article.
We trained and validated risk prediction models for the three major types of skin cancer- basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma-on a cross-sectional and longitudinal dataset of 210,000 consented research partici …
We trained and validated risk prediction models for the three major types of skin cancer- basal cell carcinoma (BCC), s …
Genome-Wide Expression Difference of MicroRNAs in Basal Cell Carcinoma.
Wei HP, Zhan S, Zhu QA, Chen ZJ, Feng X, Chen JY, Zhang QL, Zhao J, Meng L. Wei HP, et al. J Immunol Res. 2021 Aug 4;2021:7223500. doi: 10.1155/2021/7223500. eCollection 2021. J Immunol Res. 2021. PMID: 34395634 Free PMC article.
Distinct expression of the miRNAs has rarely been explored in basal cell carcinoma (BCC) of skin, and the regulatory role of miRNAs in BCC development remains quite opaque. ...Functional analysis of predicted target genes of DEMs in BCCs shows that these miRN …
Distinct expression of the miRNAs has rarely been explored in basal cell carcinoma (BCC) of skin, and the regulatory ro …
The Promise of Genomics and the Development of Targeted Therapies for Cutaneous Squamous Cell Carcinoma.
Harwood CA, Proby CM, Inman GJ, Leigh IM. Harwood CA, et al. Acta Derm Venereol. 2016 Jan;96(1):3-16. doi: 10.2340/00015555-2181. Acta Derm Venereol. 2016. PMID: 26084328 Free article. Review.
Targeted therapies for melanoma and basal cell carcinoma have evolved from deciphering the molecular mechanisms involved in their tumorigenesis. Mutations in BRAF have led to clinical use of BRAF-inhibitors in advanced melanoma, and mutations in Hedgeh …
Targeted therapies for melanoma and basal cell carcinoma have evolved from deciphering the molecular mechanisms involve …
Basal cell carcinoma genetic susceptibility increases the rate of skin ageing: a Mendelian randomization study.
van der Poort EKJ, Gunn DA, Beekman M, Griffiths CEM, Slagboom PE, van Heemst D, Noordam R. van der Poort EKJ, et al. J Eur Acad Dermatol Venereol. 2020 Jan;34(1):97-100. doi: 10.1111/jdv.15880. Epub 2019 Sep 5. J Eur Acad Dermatol Venereol. 2020. PMID: 31419349
BACKGROUND: Onset of basal cell carcinoma (BCC) is connected to skin ageing, but it is unclear whether higher BCC genetic susceptibility drives skin ageing. OBJECTIVES: To investigate whether loci increasing genetic susceptibility to BCC also dr …
BACKGROUND: Onset of basal cell carcinoma (BCC) is connected to skin ageing, but it is unclear whether higher BCC genet …
Basal-cell carcinoma incidence and associated risk factors in U.S. women and men.
Wu S, Han J, Li WQ, Li T, Qureshi AA. Wu S, et al. Am J Epidemiol. 2013 Sep 15;178(6):890-7. doi: 10.1093/aje/kwt073. Epub 2013 Jul 4. Am J Epidemiol. 2013. PMID: 23828250 Free PMC article.
There is a paucity of data on basal-cell carcinoma (BCC) in the United States, since most national registries do not collect information on BCC. ...Age-adjusted BCC incidence rates increased from 519 cases per 100,000 person-years to 1,019 cases per 10 …
There is a paucity of data on basal-cell carcinoma (BCC) in the United States, since most national registries do not co …
A comprehensive re-assessment of the association between vitamin D and cancer susceptibility using Mendelian randomization.
Ong JS, Dixon-Suen SC, Han X, An J; Esophageal Cancer Consortium; 23 and Me Research Team; Liyanage U, Dusingize JC, Schumacher J, Gockel I, Böhmer A, Jankowski J, Palles C, O'Mara T, Spurdle A, Law MH, Iles MM, Pharoah P, Berchuck A, Zheng W, Thrift AP, Olsen C, Neale RE, Gharahkhani P, Webb PM, MacGregor S. Ong JS, et al. Nat Commun. 2021 Jan 11;12(1):246. doi: 10.1038/s41467-020-20368-w. Nat Commun. 2021. PMID: 33431812 Free PMC article.
Previous Mendelian randomization (MR) studies on 25-hydroxyvitamin D (25(OH)D) and cancer have typically adopted a handful of variants and found no relationship between 25(OH)D and cancer; however, issues of horizontal pleiotropy cannot be reliably addressed. ...Our findin …
Previous Mendelian randomization (MR) studies on 25-hydroxyvitamin D (25(OH)D) and cancer have typically adopted a handful of variant …
Basal cell carcinoma: review of epidemiology, pathogenesis, and associated risk factors.
Lear W, Dahlke E, Murray CA. Lear W, et al. J Cutan Med Surg. 2007 Jan-Feb;11(1):19-30. doi: 10.2310/7750.2007.00011. J Cutan Med Surg. 2007. PMID: 17274935 Review.
BACKGROUND: Basal cell carcinoma (BCC) is extremely common, and its incidence continues to rise. ...
BACKGROUND: Basal cell carcinoma (BCC) is extremely common, and its incidence continues to rise. ...
74 results